pitolisant (Wakix)
Jump to navigation
Jump to search
Indications
- treatment of narcolepsy*
* only nonscheduled treatment option FDA-approved for adult patients with narcolepsy
Contraindications
- severe liver disease or ESRD
- risk of QT prolongation
Dosage
- QAM upon awakening
Adverse effects
Mechanism of action
- increases synthesis & release of histamine, a wake-promoting neurotransmitter in the brain
More general terms
References
- ↑ Brooks M. FDA Okays Pitolisant (Wakix) for Narcolepsy. Medscape - Aug 15, 2019. https://www.medscape.com/viewarticle/916895
- ↑ HIGHLIGHTS OF PRESCRIBING INFORMATION WAKIX<TM> (pitolisant) tablets, for oral use https://www.wakix.com/assets/pdf/wakix_prescribinginformation_us.pdf